Physiological actions of renal collecting duct endothelin

Jeffrey L. Garvin1,2 and Marcela Herrera1

1Division of Hypertension and Vascular Research, Henry Ford Hospital, and 2Department of Physiology, Wayne State University, Detroit, Michigan

THE CONTRIBUTION OF ENDOTHELIN to regulation of renal function under normal physiological conditions is unclear. Many cells in the kidney produce endothelin (9). Endothelin has been reported to have effects that both promote (2, 3, 57, 1214, 16, 18) and reduce (2, 8, 13, 15) urinary sodium excretion and urinary volume. This may be due to the fact that endothelin exerts its effects via two receptor subtypes, ETA and ETB (4, 13). The fact that endogenously produced endothelin can act via two distinct receptors that have opposite effects has made it impossible to be certain whether endogenous endothelin is natriuretic or diuretic under physiological conditions, or how endothelin produced in specific nephron segments contributes to these processes.

In "Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality" the authors (3a) deleted the endothelin gene specifically from the collecting duct, thereby eliminating it as a source of endothelin, and tested the resulting effect on the ability of mice to excrete both acute and chronic water loads. Thus this paper demonstrates the technology to dissect the contributions of endothelin from different renal cell types under relatively normal circumstances. The authors found that mice with endothelin deleted from the collecting duct could not eliminate an acute volume load as well as wild-type mice, but there was no difference in the ability of the two strains to eliminate a chronic water load. Infusion of a selective V2 receptor agonist increased urine osmolality, aquaporin-2 phosphorylation, and V2 receptor expression to a greater extent in the knockout mice than the wild-type mice. The authors conclude that endothelin produced by the collecting duct functions as an autacoid to blunt the physiological actions of vasopressin.

Publication of the manuscript "Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality" represents a milestone in renal physiology for its specific conclusions regarding endothelin and more importantly for the technology that it demonstrates. Historically, we have been divided into two camps: those who study renal function using a reductionist approach using isolated cells and individual segments; and those who study renal function in vivo. The complexity of the kidney, with its nearly 20 different tissue types arranged in a complex geometry that also impacts on function, has slowed progress of both the reductionist and whole animal approaches to understanding the kidney. The advent of technology that allows manipulation of specific genes in specific tissues in the kidney held the promise of being able to study the role of a specific molecule in a specific tissue in renal physiology in vivo with geometry intact. Over the past few years, several advances have been made using such technology. The most rudimentary of these were knockout mice with deletion of a gene whose expression was limited to a few tissues in the body, such as the Na-K-2Cl cotransporter NKCC2. However, homozygous –/– mice were not viable and animals having only one copy of the NKCC2 gene had no overt phenotype (17). The next steps included overexpressing a specific gene such as the renin gene in the proximal tubule (10) and rescue of a deleted gene such as nitric oxide synthase 3 in the thick ascending limb (11). However, in these models, the transgene is not under the control of the native promoter. The potential of gene manipulation technology has now taken another significant step forward with the publication of "Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality" (3a) and "Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention" (1) by the same group. These two papers demonstrate tissue-specific knockout of an autocrine/paracrine factor in the kidney and its physiological consequences. They unequivocally show that endothelin produced by the collecting duct promotes diuresis under physiological circumstances. Thus they move us a significant step closer to the ultimate goal of studying the physiological actions of a single protein in a single cell type at a specific point in time in vivo.


    FOOTNOTES
 

Address for reprint requests and other correspondence: J. L. Garvin, Division of Hypertension and Vascular Research, Henry Ford Hospital, 2799 West Grand Blvd., Detroit, MI 48202 (E-mail: jgarvin1{at}hfhs.org)


    REFERENCES
 TOP
 REFERENCES
 

  1. Ahn D, Ge Y, Stricklett PK, Gill P, Taylor D, Hughes AK, Yanagisawa M, Miller L, Nelson RD, and Kohan DE. Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention. J Clin Invest 114: 504–511, 2004.[Abstract/Free Full Text]
  2. Garcia NH and Garvin JL. Endothelin's biphasic effect on fluid absorption in the proximal straight tubule and its inhibitory cascade. J Clin Invest 93: 2572–2577, 1994.[ISI][Medline]
  3. Garvin J and Sanders K. Endothelin inhibits fluid and bicarbonate transport in part by reducing Na+/K+ ATPase activity in the rat proximal straight tubule. J Am Soc Nephrol 2: 976–982, 1991.[Abstract]
  4. Ge Y, Ahn D, Stricklett PK, Hughes AK, Yanagisawa M, Verbalis JG, and Kohan DE. Collecting duct-specific knockout of endothelin-1 alters vasopressin regulation of urine osmolality. Am J Physiol Renal Physiol 288: F912–F920, 2005.
  5. Granger JP. Endothelin. Am J Physiol Regul Integr Comp Physiol 285: R298–R301, 2003.[Free Full Text]
  6. Herrera M and Garvin JL. Endothelin stimulates endothelial nitric oxide synthase expression in the thick ascending limb. Am J Physiol Renal Physiol 287: F231–F235, 2004.[Abstract/Free Full Text]
  7. Herrera M and Garvin JL. A high-salt diet stimulates thick ascending limb eNOS expression by raising medullary osmolality and increasing release of endothelin-1. Am J Physiol Renal Physiol 288: F58–F64, 2005.[Abstract/Free Full Text]
  8. Hoffman A, Grossman E, Goldstein DS, Gill JR Jr, and HR Keiser. Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity. Kidney Int 45: 556–560, 1994.[ISI][Medline]
  9. Kato T, Kassab S, Wilkins FC Jr, Kirchner KA, Keiser J, and Granger JP. Endothelin antagonists improve renal function in spontaneously hypertensive rats. Hypertension 25: 883–887, 1995.[Abstract/Free Full Text]
  10. Kohan DE. Endothelin synthesis by rabbit renal tubule cells. Am J Physiol Renal Fluid Electrolyte Physiol 261: F221–F226, 1991.[Abstract/Free Full Text]
  11. Lavoie JL, Lake-Bruse KD, and Sigmund CD. Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule. Am J Physiol Renal Physiol 286: F965–F971, 2004.[Abstract/Free Full Text]
  12. Ortiz PA, Hong NJ, Wang D, and Garvin JL. Gene transfer of eNOS to the thick ascending limb of eNOS-KO mice restores the effects of L-arginine on NaCl absorption. Hypertension 42: 674–679, 2003.[Abstract/Free Full Text]
  13. Plato CF, Pollock DM, and Garvin JL. Endothelin inhibits thick ascending limb chloride flux via ET(B) receptor-mediated NO release. Am J Physiol Renal Physiol 279: F326–F333, 2000.[Abstract/Free Full Text]
  14. Pollock DM. Renal endothelin in hypertension. Curr Opin Nephrol Hypertens 9: 157–164, 2000.[CrossRef][ISI][Medline]
  15. Pollock DM, Allcock GH, Krishnan A, Dayton BD, and Pollock JS. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats. Am J Physiol Renal Physiol 278: F279–F286, 2000.[Abstract/Free Full Text]
  16. Pollock DM and Polakowski JS. ETA receptor blockade prevents hypertension associated with exogenous endothelin-1 but not renal mass reduction in the rat. J Am Soc Nephrol 8: 1054–1060, 1997.[Abstract]
  17. Pollock DM and Pollock JS. Evidence for endothelin involvement in the response to high salt. Am J Physiol Renal Physiol 281: F144–F150, 2001.[Abstract/Free Full Text]
  18. Takahashi N, Brooks HL, Wade JB, Liu W, Kondo Y, Ito S, Knepper MA, and Smithies O. Posttranscriptional compensation for heterozygous disruption of the kidney-specific NaK2Cl cotransporter gene. J Am Soc Nephrol 13: 604–610, 2002.[Abstract/Free Full Text]
  19. Vassileva I, Mountain C, and Pollock DM. Functional role of ETB receptors in the renal medulla. Hypertension 41: 1359–1363, 2003.[Abstract/Free Full Text]




This Article
Full Text (PDF)
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Google Scholar
Articles by Garvin, J. L.
Articles by Herrera, M.
Articles citing this Article
PubMed
PubMed Citation
Articles by Garvin, J. L.
Articles by Herrera, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.